From Sarcomeric Mutations to Heart Disease: Understanding Familial Hypertrophic Cardiomyopathy
Open Access
- 1 January 2002
- journal article
- review article
- Published by Cold Spring Harbor Laboratory
- Vol. 67, 409-416
- https://doi.org/10.1101/sqb.2002.67.409
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivoProceedings of the National Academy of Sciences, 2002
- The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic miceThe EMBO Journal, 2000
- TRANSCRIPTIONAL CONTROL OF MUSCLE DEVELOPMENT BY MYOCYTE ENHANCER FACTOR-2 (MEF2) PROTEINSAnnual Review of Cell and Developmental Biology, 1998
- Familial Hypertrophic CardiomyopathyCirculation Research, 1998